The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study. [electronic resource]
Producer: 20111128Description: 1487-93 p. digitalISSN:- 1462-0332
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- blood
- Autoantibodies -- blood
- Biomarkers -- blood
- Female
- Health Status
- Humans
- Infliximab
- Joints -- pathology
- Male
- Middle Aged
- Peptides, Cyclic -- blood
- Prognosis
- Rheumatoid Factor -- blood
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.